Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T69317 |
Dexverapamil
|
||
Dexverapamil is the R-enantiomer of the calcium channel blocker verapamil. Dexverapamil competitively inhibits the multidrug resistance efflux pump P-glycoprotein (MDR-1), thereby potentially increasing the effectiveness of a wide range of antineoplastic drugs which are inactivated by MDR-1 mechanisms. |